TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has issued an announcement.
Vitrafy Life Sciences Ltd. announced the quotation of 8,744,376 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 21, 2025. This move is expected to enhance the company’s market presence and provide additional capital for its growth initiatives, potentially impacting its operational capabilities and industry positioning positively.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Ltd. operates in the life sciences industry, focusing on innovative solutions and technologies to enhance healthcare outcomes. The company is engaged in the development and commercialization of advanced life science products, aiming to address critical needs in the healthcare sector.
Average Trading Volume: 26,392
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$93.86M
For an in-depth examination of VFY stock, go to TipRanks’ Overview page.